Antiviral Therapy Reduces Hepatocellular Carcinoma Recurrence in Patients With Low HBV-DNA LevelsGang Huang, Weiping Zhou, Pengpeng Li et al.|Annals of Surgery|2018Cited by 161
Plasma circular RNA panel to diagnose hepatitis B virus‐related hepatocellular carcinoma: A large‐scale, multicenter studyJian Yu, Weiping Zhou, Jing‐feng Liu et al.|International Journal of Cancer|2019Cited by 114
A High Preoperative Platelet-Lymphocyte Ratio Is a Negative Predictor of Survival After Liver Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Retrospective StudyYun Yang, Weiping Zhou, Meng‐chao Wang et al.|Frontiers in Oncology|2020Cited by 25
Antiviral therapy to reduce hepatocellular carcinoma recurrence in patients with low HBV-DNA levels: A randomized controlled trial.Gang Huang, Weiping Zhou, Pengpeng Li et al.|Journal of Clinical Oncology|2019Cited by 0